nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2B6—Thiotepa—urinary bladder cancer	0.149	0.315	CbGbCtD
Sevoflurane—CYP2A6—Fluorouracil—urinary bladder cancer	0.0742	0.157	CbGbCtD
Sevoflurane—ALB—Fluorouracil—urinary bladder cancer	0.0473	0.1	CbGbCtD
Sevoflurane—CYP3A4—Thiotepa—urinary bladder cancer	0.0457	0.0967	CbGbCtD
Sevoflurane—CYP2B6—Cisplatin—urinary bladder cancer	0.041	0.0869	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—urinary bladder cancer	0.0408	0.0866	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—urinary bladder cancer	0.0275	0.0582	CbGbCtD
Sevoflurane—ALB—Methotrexate—urinary bladder cancer	0.0261	0.0553	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—urinary bladder cancer	0.0124	0.0262	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—urinary bladder cancer	0.00844	0.0179	CbGbCtD
Sevoflurane—KCNK2—prostate gland—urinary bladder cancer	0.00759	0.0518	CbGeAlD
Sevoflurane—KCNK10—renal system—urinary bladder cancer	0.00554	0.0378	CbGeAlD
Sevoflurane—ND1—prostate gland—urinary bladder cancer	0.00508	0.0347	CbGeAlD
Sevoflurane—KCNK3—renal system—urinary bladder cancer	0.005	0.0341	CbGeAlD
Sevoflurane—CYP2E1—urine—urinary bladder cancer	0.00455	0.031	CbGeAlD
Sevoflurane—ATP5D—prostate gland—urinary bladder cancer	0.0041	0.0279	CbGeAlD
Sevoflurane—ATP2C1—prostate gland—urinary bladder cancer	0.00404	0.0276	CbGeAlD
Sevoflurane—KCNK3—female reproductive system—urinary bladder cancer	0.004	0.0273	CbGeAlD
Sevoflurane—GABRP—prostate gland—urinary bladder cancer	0.00396	0.027	CbGeAlD
Sevoflurane—KCNK2—vagina—urinary bladder cancer	0.00375	0.0256	CbGeAlD
Sevoflurane—CYP3A4—urine—urinary bladder cancer	0.00366	0.0249	CbGeAlD
Sevoflurane—ND1—smooth muscle tissue—urinary bladder cancer	0.0036	0.0245	CbGeAlD
Sevoflurane—ATP5D—seminal vesicle—urinary bladder cancer	0.00347	0.0236	CbGeAlD
Sevoflurane—ND1—renal system—urinary bladder cancer	0.00346	0.0236	CbGeAlD
Sevoflurane—CYP2A6—prostate gland—urinary bladder cancer	0.00345	0.0235	CbGeAlD
Sevoflurane—ATP2C1—seminal vesicle—urinary bladder cancer	0.00342	0.0233	CbGeAlD
Sevoflurane—GABRE—prostate gland—urinary bladder cancer	0.00303	0.0206	CbGeAlD
Sevoflurane—CYP2A6—seminal vesicle—urinary bladder cancer	0.00292	0.0199	CbGeAlD
Sevoflurane—ATP5D—smooth muscle tissue—urinary bladder cancer	0.0029	0.0198	CbGeAlD
Sevoflurane—ATP2C1—smooth muscle tissue—urinary bladder cancer	0.00286	0.0195	CbGeAlD
Sevoflurane—ATP5D—renal system—urinary bladder cancer	0.00279	0.019	CbGeAlD
Sevoflurane—ND1—female reproductive system—urinary bladder cancer	0.00277	0.0189	CbGeAlD
Sevoflurane—ATP2C1—renal system—urinary bladder cancer	0.00276	0.0188	CbGeAlD
Sevoflurane—ATP5D—urethra—urinary bladder cancer	0.00274	0.0187	CbGeAlD
Sevoflurane—ATP2C1—urethra—urinary bladder cancer	0.00271	0.0185	CbGeAlD
Sevoflurane—GABRP—urethra—urinary bladder cancer	0.00265	0.0181	CbGeAlD
Sevoflurane—GABRB3—prostate gland—urinary bladder cancer	0.00256	0.0175	CbGeAlD
Sevoflurane—GABRE—seminal vesicle—urinary bladder cancer	0.00256	0.0174	CbGeAlD
Sevoflurane—KCNK2—lymph node—urinary bladder cancer	0.00242	0.0165	CbGeAlD
Sevoflurane—ATP5D—female reproductive system—urinary bladder cancer	0.00224	0.0152	CbGeAlD
Sevoflurane—ATP2C1—female reproductive system—urinary bladder cancer	0.00221	0.015	CbGeAlD
Sevoflurane—GABRB1—vagina—urinary bladder cancer	0.00218	0.0149	CbGeAlD
Sevoflurane—GABRP—female reproductive system—urinary bladder cancer	0.00216	0.0148	CbGeAlD
Sevoflurane—GABRE—urethra—urinary bladder cancer	0.00203	0.0138	CbGeAlD
Sevoflurane—ATP5D—vagina—urinary bladder cancer	0.00202	0.0138	CbGeAlD
Sevoflurane—ATP2C1—vagina—urinary bladder cancer	0.002	0.0136	CbGeAlD
Sevoflurane—GABRP—vagina—urinary bladder cancer	0.00196	0.0133	CbGeAlD
Sevoflurane—CYP2A6—vagina—urinary bladder cancer	0.0017	0.0116	CbGeAlD
Sevoflurane—GABRE—female reproductive system—urinary bladder cancer	0.00165	0.0113	CbGeAlD
Sevoflurane—CYP2E1—prostate gland—urinary bladder cancer	0.00163	0.0111	CbGeAlD
Sevoflurane—ND1—lymph node—urinary bladder cancer	0.00162	0.0111	CbGeAlD
Sevoflurane—GABRA2—vagina—urinary bladder cancer	0.00151	0.0103	CbGeAlD
Sevoflurane—GABRE—vagina—urinary bladder cancer	0.00149	0.0102	CbGeAlD
Sevoflurane—GABRB3—female reproductive system—urinary bladder cancer	0.0014	0.00955	CbGeAlD
Sevoflurane—CYP2E1—seminal vesicle—urinary bladder cancer	0.00138	0.00941	CbGeAlD
Sevoflurane—ATP5D—lymph node—urinary bladder cancer	0.00131	0.00892	CbGeAlD
Sevoflurane—ATP2C1—lymph node—urinary bladder cancer	0.00129	0.0088	CbGeAlD
Sevoflurane—CYP2B6—renal system—urinary bladder cancer	0.00119	0.00808	CbGeAlD
Sevoflurane—CYP2E1—renal system—urinary bladder cancer	0.00111	0.00758	CbGeAlD
Sevoflurane—CYP2E1—urethra—urinary bladder cancer	0.00109	0.00745	CbGeAlD
Sevoflurane—GABRA2—lymph node—urinary bladder cancer	0.000974	0.00664	CbGeAlD
Sevoflurane—GABRE—lymph node—urinary bladder cancer	0.000966	0.00659	CbGeAlD
Sevoflurane—CYP2B6—female reproductive system—urinary bladder cancer	0.000949	0.00647	CbGeAlD
Sevoflurane—CYP3A4—renal system—urinary bladder cancer	0.000895	0.0061	CbGeAlD
Sevoflurane—CYP2E1—female reproductive system—urinary bladder cancer	0.000891	0.00607	CbGeAlD
Sevoflurane—ALB—lymph node—urinary bladder cancer	0.000881	0.00601	CbGeAlD
Sevoflurane—CYP2B6—vagina—urinary bladder cancer	0.000858	0.00585	CbGeAlD
Sevoflurane—CYP3A4—female reproductive system—urinary bladder cancer	0.000717	0.00489	CbGeAlD
Sevoflurane—Cough—Etoposide—urinary bladder cancer	0.000497	0.00156	CcSEcCtD
Sevoflurane—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000497	0.00156	CcSEcCtD
Sevoflurane—Tachycardia—Cisplatin—urinary bladder cancer	0.000495	0.00155	CcSEcCtD
Sevoflurane—Convulsion—Etoposide—urinary bladder cancer	0.000494	0.00155	CcSEcCtD
Sevoflurane—Skin disorder—Cisplatin—urinary bladder cancer	0.000493	0.00155	CcSEcCtD
Sevoflurane—Insomnia—Gemcitabine—urinary bladder cancer	0.000493	0.00155	CcSEcCtD
Sevoflurane—Hypertension—Etoposide—urinary bladder cancer	0.000492	0.00154	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00049	0.00154	CcSEcCtD
Sevoflurane—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000486	0.00152	CcSEcCtD
Sevoflurane—Chest pain—Etoposide—urinary bladder cancer	0.000485	0.00152	CcSEcCtD
Sevoflurane—Insomnia—Fluorouracil—urinary bladder cancer	0.000484	0.00152	CcSEcCtD
Sevoflurane—Somnolence—Gemcitabine—urinary bladder cancer	0.000484	0.00152	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000482	0.00151	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—urinary bladder cancer	0.00048	0.00151	CcSEcCtD
Sevoflurane—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000477	0.0015	CcSEcCtD
Sevoflurane—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000477	0.0015	CcSEcCtD
Sevoflurane—Somnolence—Fluorouracil—urinary bladder cancer	0.000476	0.00149	CcSEcCtD
Sevoflurane—Hypotension—Cisplatin—urinary bladder cancer	0.000474	0.00149	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00047	0.00148	CcSEcCtD
Sevoflurane—Confusional state—Etoposide—urinary bladder cancer	0.000469	0.00147	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000467	0.00146	CcSEcCtD
Sevoflurane—Pain—Gemcitabine—urinary bladder cancer	0.000466	0.00146	CcSEcCtD
Sevoflurane—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000465	0.00146	CcSEcCtD
Sevoflurane—Asthenia—Thiotepa—urinary bladder cancer	0.000465	0.00146	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000462	0.00145	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—urinary bladder cancer	0.000458	0.00144	CcSEcCtD
Sevoflurane—Pruritus—Thiotepa—urinary bladder cancer	0.000458	0.00144	CcSEcCtD
Sevoflurane—Pain—Fluorouracil—urinary bladder cancer	0.000458	0.00144	CcSEcCtD
Sevoflurane—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000455	0.00143	CcSEcCtD
Sevoflurane—Tachycardia—Etoposide—urinary bladder cancer	0.000454	0.00142	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000453	0.00142	CcSEcCtD
Sevoflurane—Dyspnoea—Cisplatin—urinary bladder cancer	0.000453	0.00142	CcSEcCtD
Sevoflurane—Skin disorder—Etoposide—urinary bladder cancer	0.000452	0.00142	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—urinary bladder cancer	0.000449	0.00141	CcSEcCtD
Sevoflurane—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000449	0.00141	CcSEcCtD
Sevoflurane—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000441	0.00138	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000438	0.00138	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—urinary bladder cancer	0.000435	0.00136	CcSEcCtD
Sevoflurane—Pain—Cisplatin—urinary bladder cancer	0.000434	0.00136	CcSEcCtD
Sevoflurane—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000431	0.00135	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—urinary bladder cancer	0.000429	0.00135	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—urinary bladder cancer	0.000429	0.00135	CcSEcCtD
Sevoflurane—Dizziness—Thiotepa—urinary bladder cancer	0.000428	0.00134	CcSEcCtD
Sevoflurane—Urticaria—Fluorouracil—urinary bladder cancer	0.000425	0.00133	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000425	0.00133	CcSEcCtD
Sevoflurane—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000423	0.00133	CcSEcCtD
Sevoflurane—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000418	0.00131	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000416	0.00131	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—urinary bladder cancer	0.000415	0.0013	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000414	0.0013	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—urinary bladder cancer	0.000413	0.0013	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000413	0.0013	CcSEcCtD
Sevoflurane—Vomiting—Thiotepa—urinary bladder cancer	0.000412	0.00129	CcSEcCtD
Sevoflurane—Rash—Thiotepa—urinary bladder cancer	0.000408	0.00128	CcSEcCtD
Sevoflurane—Dermatitis—Thiotepa—urinary bladder cancer	0.000408	0.00128	CcSEcCtD
Sevoflurane—Headache—Thiotepa—urinary bladder cancer	0.000406	0.00127	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—urinary bladder cancer	0.000402	0.00126	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000402	0.00126	CcSEcCtD
Sevoflurane—Body temperature increased—Cisplatin—urinary bladder cancer	0.000401	0.00126	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—urinary bladder cancer	0.000398	0.00125	CcSEcCtD
Sevoflurane—Pain—Etoposide—urinary bladder cancer	0.000398	0.00125	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000397	0.00125	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—urinary bladder cancer	0.000397	0.00124	CcSEcCtD
Sevoflurane—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000395	0.00124	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—urinary bladder cancer	0.000394	0.00124	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—urinary bladder cancer	0.000392	0.00123	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—urinary bladder cancer	0.000392	0.00123	CcSEcCtD
Sevoflurane—Asthenia—Gemcitabine—urinary bladder cancer	0.000391	0.00123	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—urinary bladder cancer	0.000389	0.00122	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000387	0.00122	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000387	0.00121	CcSEcCtD
Sevoflurane—Pruritus—Gemcitabine—urinary bladder cancer	0.000385	0.00121	CcSEcCtD
Sevoflurane—Nausea—Thiotepa—urinary bladder cancer	0.000385	0.00121	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—urinary bladder cancer	0.000384	0.00121	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—urinary bladder cancer	0.000383	0.0012	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000383	0.0012	CcSEcCtD
Sevoflurane—Pruritus—Fluorouracil—urinary bladder cancer	0.000379	0.00119	CcSEcCtD
Sevoflurane—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000374	0.00117	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—urinary bladder cancer	0.000374	0.00117	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—urinary bladder cancer	0.000372	0.00117	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—urinary bladder cancer	0.000369	0.00116	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—urinary bladder cancer	0.000369	0.00116	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—urinary bladder cancer	0.000369	0.00116	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—urinary bladder cancer	0.000368	0.00115	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000368	0.00115	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—urinary bladder cancer	0.000367	0.00115	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—urinary bladder cancer	0.000367	0.00115	CcSEcCtD
Sevoflurane—Asthenia—Cisplatin—urinary bladder cancer	0.000364	0.00114	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—urinary bladder cancer	0.000364	0.00114	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000364	0.00114	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000362	0.00114	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—urinary bladder cancer	0.00036	0.00113	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000358	0.00112	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—urinary bladder cancer	0.000356	0.00112	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—urinary bladder cancer	0.000354	0.00111	CcSEcCtD
Sevoflurane—Dizziness—Fluorouracil—urinary bladder cancer	0.000354	0.00111	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000353	0.00111	CcSEcCtD
Sevoflurane—Chills—Methotrexate—urinary bladder cancer	0.000352	0.0011	CcSEcCtD
Sevoflurane—Vomiting—Gemcitabine—urinary bladder cancer	0.000346	0.00109	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—urinary bladder cancer	0.000346	0.00108	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—urinary bladder cancer	0.000344	0.00108	CcSEcCtD
Sevoflurane—Rash—Gemcitabine—urinary bladder cancer	0.000343	0.00108	CcSEcCtD
Sevoflurane—Dermatitis—Gemcitabine—urinary bladder cancer	0.000343	0.00108	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—urinary bladder cancer	0.000343	0.00108	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—urinary bladder cancer	0.000341	0.00107	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000341	0.00107	CcSEcCtD
Sevoflurane—Headache—Gemcitabine—urinary bladder cancer	0.000341	0.00107	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000341	0.00107	CcSEcCtD
Sevoflurane—Vomiting—Fluorouracil—urinary bladder cancer	0.00034	0.00107	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00034	0.00107	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—urinary bladder cancer	0.00034	0.00107	CcSEcCtD
Sevoflurane—Rash—Fluorouracil—urinary bladder cancer	0.000338	0.00106	CcSEcCtD
Sevoflurane—Dermatitis—Fluorouracil—urinary bladder cancer	0.000337	0.00106	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000337	0.00106	CcSEcCtD
Sevoflurane—Headache—Fluorouracil—urinary bladder cancer	0.000335	0.00105	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000335	0.00105	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—urinary bladder cancer	0.000334	0.00105	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—urinary bladder cancer	0.000334	0.00105	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—urinary bladder cancer	0.000333	0.00104	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000333	0.00104	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—urinary bladder cancer	0.000331	0.00104	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000331	0.00104	CcSEcCtD
Sevoflurane—Chills—Epirubicin—urinary bladder cancer	0.000329	0.00103	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—urinary bladder cancer	0.000329	0.00103	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—urinary bladder cancer	0.000328	0.00103	CcSEcCtD
Sevoflurane—Nausea—Gemcitabine—urinary bladder cancer	0.000324	0.00102	CcSEcCtD
Sevoflurane—Vomiting—Cisplatin—urinary bladder cancer	0.000323	0.00101	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—urinary bladder cancer	0.000321	0.00101	CcSEcCtD
Sevoflurane—Rash—Cisplatin—urinary bladder cancer	0.00032	0.001	CcSEcCtD
Sevoflurane—Dermatitis—Cisplatin—urinary bladder cancer	0.00032	0.001	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—urinary bladder cancer	0.000319	0.001	CcSEcCtD
Sevoflurane—Nausea—Fluorouracil—urinary bladder cancer	0.000318	0.000998	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000315	0.000989	CcSEcCtD
Sevoflurane—Tension—Epirubicin—urinary bladder cancer	0.000313	0.000984	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—urinary bladder cancer	0.000313	0.000982	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—urinary bladder cancer	0.00031	0.000974	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—urinary bladder cancer	0.000308	0.000967	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—urinary bladder cancer	0.000308	0.000965	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000307	0.000962	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000306	0.00096	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—urinary bladder cancer	0.000305	0.000956	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000303	0.000952	CcSEcCtD
Sevoflurane—Nausea—Cisplatin—urinary bladder cancer	0.000302	0.000946	CcSEcCtD
Sevoflurane—Cough—Methotrexate—urinary bladder cancer	0.000298	0.000935	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—urinary bladder cancer	0.000297	0.000933	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—urinary bladder cancer	0.000296	0.000928	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—urinary bladder cancer	0.000296	0.000928	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—urinary bladder cancer	0.000296	0.000927	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—urinary bladder cancer	0.000294	0.000921	CcSEcCtD
Sevoflurane—Rash—Etoposide—urinary bladder cancer	0.000293	0.00092	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—urinary bladder cancer	0.000293	0.000919	CcSEcCtD
Sevoflurane—Headache—Etoposide—urinary bladder cancer	0.000291	0.000914	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—urinary bladder cancer	0.000291	0.000912	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—urinary bladder cancer	0.00029	0.00091	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000289	0.000908	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000289	0.000906	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—urinary bladder cancer	0.000287	0.000901	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—urinary bladder cancer	0.000286	0.000899	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—urinary bladder cancer	0.000281	0.000881	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000281	0.000881	CcSEcCtD
Sevoflurane—Cough—Epirubicin—urinary bladder cancer	0.000279	0.000875	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000279	0.000874	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—urinary bladder cancer	0.000277	0.000868	CcSEcCtD
Sevoflurane—Nausea—Etoposide—urinary bladder cancer	0.000276	0.000867	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—urinary bladder cancer	0.000276	0.000865	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000273	0.000857	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000273	0.000856	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—urinary bladder cancer	0.000272	0.000853	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—urinary bladder cancer	0.000272	0.000852	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—urinary bladder cancer	0.000271	0.000849	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00027	0.000847	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—urinary bladder cancer	0.000266	0.000835	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—urinary bladder cancer	0.000265	0.000832	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—urinary bladder cancer	0.000263	0.000825	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000261	0.000818	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—urinary bladder cancer	0.000261	0.000818	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—urinary bladder cancer	0.00026	0.000817	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00026	0.000815	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—urinary bladder cancer	0.000258	0.000809	CcSEcCtD
Sevoflurane—Shock—Epirubicin—urinary bladder cancer	0.000256	0.000805	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—urinary bladder cancer	0.000256	0.000804	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000256	0.000802	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000255	0.000801	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—urinary bladder cancer	0.000255	0.000801	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—urinary bladder cancer	0.000254	0.000798	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—urinary bladder cancer	0.000253	0.000795	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—urinary bladder cancer	0.000252	0.000791	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—urinary bladder cancer	0.000252	0.00079	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00025	0.000784	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—urinary bladder cancer	0.000248	0.000779	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—urinary bladder cancer	0.000248	0.000777	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—urinary bladder cancer	0.000246	0.000772	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—urinary bladder cancer	0.000244	0.000764	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—urinary bladder cancer	0.000243	0.000763	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—urinary bladder cancer	0.000241	0.000757	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000241	0.000757	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000241	0.000755	CcSEcCtD
Sevoflurane—Pain—Methotrexate—urinary bladder cancer	0.000238	0.000748	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—urinary bladder cancer	0.000237	0.000745	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000237	0.000742	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000236	0.000741	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—urinary bladder cancer	0.000236	0.00074	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—urinary bladder cancer	0.000235	0.000739	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000735	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—urinary bladder cancer	0.000232	0.000729	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—urinary bladder cancer	0.000232	0.000727	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00023	0.00072	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—urinary bladder cancer	0.000225	0.000707	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000225	0.000706	CcSEcCtD
Sevoflurane—Pain—Epirubicin—urinary bladder cancer	0.000223	0.0007	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—urinary bladder cancer	0.000221	0.000694	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—urinary bladder cancer	0.00022	0.000691	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—urinary bladder cancer	0.000218	0.000685	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000215	0.000675	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000215	0.000674	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—urinary bladder cancer	0.000214	0.000673	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000208	0.000653	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—urinary bladder cancer	0.000207	0.00065	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—urinary bladder cancer	0.000206	0.000647	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—urinary bladder cancer	0.000206	0.000647	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000205	0.000644	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—urinary bladder cancer	0.0002	0.000627	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000199	0.000624	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—urinary bladder cancer	0.000197	0.000618	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000192	0.000603	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—urinary bladder cancer	0.000192	0.000601	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000191	0.000598	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—urinary bladder cancer	0.000187	0.000587	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—urinary bladder cancer	0.000184	0.000579	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—urinary bladder cancer	0.000184	0.000578	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000178	0.000558	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—urinary bladder cancer	0.000177	0.000556	CcSEcCtD
Sevoflurane—Rash—Methotrexate—urinary bladder cancer	0.000176	0.000551	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—urinary bladder cancer	0.000175	0.000551	CcSEcCtD
Sevoflurane—Headache—Methotrexate—urinary bladder cancer	0.000175	0.000548	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—urinary bladder cancer	0.000173	0.000543	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—urinary bladder cancer	0.000172	0.000541	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—urinary bladder cancer	0.000171	0.000536	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—urinary bladder cancer	0.000166	0.00052	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—urinary bladder cancer	0.000165	0.000519	CcSEcCtD
Sevoflurane—Rash—Epirubicin—urinary bladder cancer	0.000164	0.000516	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—urinary bladder cancer	0.000164	0.000515	CcSEcCtD
Sevoflurane—Headache—Epirubicin—urinary bladder cancer	0.000163	0.000512	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—urinary bladder cancer	0.00016	0.000501	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—urinary bladder cancer	0.000155	0.000486	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—urinary bladder cancer	0.000153	0.000481	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—urinary bladder cancer	0.000152	0.000477	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—urinary bladder cancer	0.000152	0.000477	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—urinary bladder cancer	0.000151	0.000474	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—urinary bladder cancer	0.000143	0.00045	CcSEcCtD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.1e-05	0.000973	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	6.1e-05	0.000973	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	6.01e-05	0.000959	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.99e-05	0.000955	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	5.97e-05	0.000952	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	5.76e-05	0.000919	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTP1—urinary bladder cancer	5.7e-05	0.000909	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTP1—urinary bladder cancer	5.7e-05	0.000909	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	5.61e-05	0.000896	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.48e-05	0.000874	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	5.47e-05	0.000873	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.44e-05	0.000868	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.4e-05	0.000861	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	5.37e-05	0.000858	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TYMS—urinary bladder cancer	5.3e-05	0.000845	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TYMS—urinary bladder cancer	5.3e-05	0.000845	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTM1—urinary bladder cancer	5.23e-05	0.000835	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—NCOR1—urinary bladder cancer	5.23e-05	0.000835	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NCOR1—urinary bladder cancer	5.23e-05	0.000835	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTM1—urinary bladder cancer	5.23e-05	0.000835	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.23e-05	0.000835	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	5.19e-05	0.000828	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NAT1—urinary bladder cancer	5.19e-05	0.000828	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.11e-05	0.000815	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—urinary bladder cancer	5.06e-05	0.000807	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.04e-05	0.000804	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GPX1—urinary bladder cancer	5.01e-05	0.0008	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GPX1—urinary bladder cancer	5.01e-05	0.0008	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5e-05	0.000798	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	4.94e-05	0.000788	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ERCC2—urinary bladder cancer	4.92e-05	0.000785	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ERCC2—urinary bladder cancer	4.92e-05	0.000785	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.87e-05	0.000778	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	4.75e-05	0.000757	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.73e-05	0.000754	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—MTHFR—urinary bladder cancer	4.63e-05	0.000738	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—MTHFR—urinary bladder cancer	4.63e-05	0.000738	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.61e-05	0.000736	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—urinary bladder cancer	4.57e-05	0.000729	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.48e-05	0.000715	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.43e-05	0.000708	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.42e-05	0.000705	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	4.42e-05	0.000705	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.4e-05	0.000702	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	4.33e-05	0.00069	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.32e-05	0.00069	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.29e-05	0.000685	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	4.27e-05	0.000682	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.22e-05	0.000673	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	4.2e-05	0.00067	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	4.19e-05	0.000668	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NAT1—urinary bladder cancer	4.19e-05	0.000668	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.12e-05	0.000657	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	4.1e-05	0.000654	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NAT1—urinary bladder cancer	4.1e-05	0.000654	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.06e-05	0.000647	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	4.04e-05	0.000644	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—urinary bladder cancer	4.03e-05	0.000642	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	4.01e-05	0.00064	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	3.93e-05	0.000628	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.84e-05	0.000612	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—urinary bladder cancer	3.83e-05	0.000611	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	3.83e-05	0.000611	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.79e-05	0.000605	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PPARG—urinary bladder cancer	3.75e-05	0.000599	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PPARG—urinary bladder cancer	3.75e-05	0.000599	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	3.75e-05	0.000598	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTZ1—urinary bladder cancer	3.72e-05	0.000593	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.69e-05	0.000588	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.64e-05	0.000581	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.63e-05	0.000579	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CREBBP—urinary bladder cancer	3.6e-05	0.000575	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CREBBP—urinary bladder cancer	3.6e-05	0.000575	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.58e-05	0.000572	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTO2—urinary bladder cancer	3.52e-05	0.000562	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NAT1—urinary bladder cancer	3.52e-05	0.000562	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.47e-05	0.000553	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.47e-05	0.000553	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	3.45e-05	0.00055	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.39e-05	0.000541	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	3.38e-05	0.000539	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.37e-05	0.000537	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.35e-05	0.000534	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.31e-05	0.000528	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.28e-05	0.000523	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	3.26e-05	0.00052	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.25e-05	0.000519	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.23e-05	0.000516	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.23e-05	0.000515	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—UGT2B7—urinary bladder cancer	3.22e-05	0.000514	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	3.19e-05	0.000509	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	3.17e-05	0.000506	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.17e-05	0.000506	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—urinary bladder cancer	3.15e-05	0.000503	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMP—urinary bladder cancer	3.14e-05	0.000502	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—urinary bladder cancer	3.11e-05	0.000496	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	3.11e-05	0.000496	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	3.1e-05	0.000495	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.06e-05	0.000489	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.01e-05	0.00048	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3e-05	0.000478	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.98e-05	0.000475	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.97e-05	0.000474	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—urinary bladder cancer	2.95e-05	0.000471	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—urinary bladder cancer	2.95e-05	0.000471	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—urinary bladder cancer	2.94e-05	0.000469	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.92e-05	0.000466	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—urinary bladder cancer	2.9e-05	0.000463	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.9e-05	0.000463	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.87e-05	0.000458	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.85e-05	0.000455	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NAT2—urinary bladder cancer	2.84e-05	0.000454	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.84e-05	0.000454	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.8e-05	0.000447	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.77e-05	0.000442	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.77e-05	0.000441	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.74e-05	0.000437	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PRSS3—urinary bladder cancer	2.67e-05	0.000426	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—urinary bladder cancer	2.66e-05	0.000424	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—urinary bladder cancer	2.58e-05	0.000412	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—urinary bladder cancer	2.57e-05	0.000411	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—urinary bladder cancer	2.57e-05	0.000411	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMP—urinary bladder cancer	2.54e-05	0.000405	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—urinary bladder cancer	2.53e-05	0.000404	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—urinary bladder cancer	2.49e-05	0.000397	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMP—urinary bladder cancer	2.48e-05	0.000396	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—urinary bladder cancer	2.47e-05	0.000395	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—EP300—urinary bladder cancer	2.45e-05	0.000392	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—EP300—urinary bladder cancer	2.45e-05	0.000392	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—RRM2—urinary bladder cancer	2.45e-05	0.000392	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.45e-05	0.000391	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—urinary bladder cancer	2.43e-05	0.000388	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.38e-05	0.00038	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NAT2—urinary bladder cancer	2.29e-05	0.000366	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	2.27e-05	0.000363	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO2—urinary bladder cancer	2.27e-05	0.000363	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NAT2—urinary bladder cancer	2.25e-05	0.000359	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	2.2e-05	0.000352	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.14e-05	0.000342	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMP—urinary bladder cancer	2.14e-05	0.000341	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—urinary bladder cancer	2.12e-05	0.000339	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.08e-05	0.000332	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.05e-05	0.000327	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.01e-05	0.00032	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.98e-05	0.000316	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLAU—urinary bladder cancer	1.96e-05	0.000313	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.94e-05	0.000309	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NAT2—urinary bladder cancer	1.93e-05	0.000308	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.9e-05	0.000304	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.9e-05	0.000304	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.83e-05	0.000293	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.83e-05	0.000293	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.83e-05	0.000292	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.8e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.8e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.78e-05	0.000284	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.74e-05	0.000278	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.74e-05	0.000278	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RRM2—urinary bladder cancer	1.67e-05	0.000266	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.62e-05	0.000258	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF1—urinary bladder cancer	1.6e-05	0.000255	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.57e-05	0.00025	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.000246	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.000246	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.53e-05	0.000245	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000244	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—urinary bladder cancer	1.5e-05	0.000239	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.48e-05	0.000236	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.48e-05	0.000236	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.47e-05	0.000235	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RHOA—urinary bladder cancer	1.46e-05	0.000234	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.45e-05	0.000231	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.44e-05	0.00023	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000227	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.4e-05	0.000224	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.4e-05	0.000224	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.4e-05	0.000224	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.34e-05	0.000215	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000211	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000199	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.000198	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.23e-05	0.000197	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—urinary bladder cancer	1.23e-05	0.000196	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	0.000193	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.21e-05	0.000193	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.15e-05	0.000184	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.15e-05	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	0.000181	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	0.000181	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.12e-05	0.000179	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	0.000177	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	0.000177	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EP300—urinary bladder cancer	1.1e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.08e-05	0.000173	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SRC—urinary bladder cancer	1.07e-05	0.000171	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.06e-05	0.00017	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.05e-05	0.000168	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.04e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.04e-05	0.000166	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—urinary bladder cancer	1.04e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.01e-05	0.000161	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1e-05	0.00016	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1e-05	0.00016	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	9.81e-06	0.000156	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	9.67e-06	0.000154	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—urinary bladder cancer	9.65e-06	0.000154	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—urinary bladder cancer	9.54e-06	0.000152	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOR1—urinary bladder cancer	9.54e-06	0.000152	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPX1—urinary bladder cancer	9.13e-06	0.000146	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RRM2—urinary bladder cancer	9e-06	0.000144	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ERCC2—urinary bladder cancer	8.97e-06	0.000143	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—urinary bladder cancer	8.88e-06	0.000142	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTHFR—urinary bladder cancer	8.43e-06	0.000134	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.33e-06	0.000133	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.33e-06	0.000133	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARG—urinary bladder cancer	8.12e-06	0.00013	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.08e-06	0.000129	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARG—urinary bladder cancer	7.95e-06	0.000127	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	7.92e-06	0.000126	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—urinary bladder cancer	7.89e-06	0.000126	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	7.8e-06	0.000124	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	7.64e-06	0.000122	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—urinary bladder cancer	7.55e-06	0.00012	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—urinary bladder cancer	6.9e-06	0.00011	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARG—urinary bladder cancer	6.83e-06	0.000109	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.72e-06	0.000107	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—EP300—urinary bladder cancer	6.58e-06	0.000105	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CREBBP—urinary bladder cancer	6.57e-06	0.000105	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.39e-06	0.000102	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	6.26e-06	9.98e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.6e-06	8.94e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.57e-06	8.89e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.46e-06	8.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—urinary bladder cancer	5.38e-06	8.58e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.31e-06	8.48e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.21e-06	8.31e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—EP300—urinary bladder cancer	5.2e-06	8.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.15e-06	8.22e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.15e-06	8.22e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.93e-06	7.87e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.84e-06	7.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—urinary bladder cancer	4.69e-06	7.48e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.55e-06	7.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—EP300—urinary bladder cancer	4.47e-06	7.14e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.69e-06	5.89e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.54e-06	5.66e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.9e-06	4.63e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.53e-06	4.04e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.41e-06	3.85e-05	CbGpPWpGaD
